Its important to explore all your options and consult with a financial advisor or insurance expert to make the best decision for your situation
Heidi Taipales Post Our new study is out now in Lancet Psychiatry
For patients who want to understand what good clinical oversight of GLP-1 treatment looks like in practice, including what lab work and monitoring to expect, the article on what lab tests to expect while on GLP-1 medications provides a useful reference
A large retrospective cohort study revealed that T2DM patients treated with GLP-1RAs exhibited a significantly reduced risk of developing dementia compared with those receiving other glucose-lowering therapies
Those with significant medical co-morbidities, prior CSF diversion procedures, neurovascular stenting or optic nerve sheath fenestration, those currently using GLP-1 receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors or taking drugs that could reduce ICP were excluded
And in fact it's not even how much you drink, it's how much that you absorb
